Phenyl 2-[4-(3,5-dimethyl-4-phenyl-1H-pyrazol-1-yl)phenyl]ethylcarbamate → HCID 22244612, 화합물
반응식
[CH3:1][C:2]1[C:6]([C:7]2[CH:12]=[CH:11][CH:10]=[CH:9][CH:8]=2)=[C:5]([CH3:13])[N:4]([C:14]2[CH:19]=[CH:18][C:17]([CH2:20][CH2:21][NH:22][C:23](=O)[O:24]C3C=CC=CC=3)=[CH:16][CH:15]=2)[N:3]=1.[CH3:32][N:33]([CH3:47])[CH2:34][CH2:35][O:36][C:37]1[CH:42]=[CH:41][C:40]([S:43]([NH2:46])(=[O:45])=[O:44])=[CH:39][CH:38]=1>>[CH3:32][N:33]([CH3:47])[CH2:34][CH2:35][O:36][C:37]1[CH:38]=[CH:39][C:40]([S:43]([NH:46][C:23]([NH:22][CH2:21][CH2:20][C:17]2[CH:16]=[CH:15][C:14]([N:4]3[C:5]([CH3:13])=[C:6]([C:7]4[CH:12]=[CH:11][CH:10]=[CH:9][CH:8]=4)[C:2]([CH3:1])=[N:3]3)=[CH:19][CH:18]=2)=[O:24])(=[O:45])=[O:44])=[CH:41][CH:42]=1참가 물질
3
실험 절차
The title compound was prepared according to the procedure described in step 1 of Example 42 from phenyl 2-[4-(3,5-dimethyl-4-phenyl-1H-pyrazol-1-yl)phenyl]ethylcarbamate (step 1 of Example 22) and 4-[2-(dimethylamino)ethoxy]benzenesulfonamide: 1H-NMR [CDCl3/CD3OD(4:1)] δ δ 7.87-7.84 (2H, m), 7.48-7.26 (9H, m), 7.01-6.98 (2H, m), 4.19-4.15 (2H, m), 3.46-3.41 (2H, m), 2.92-2.82 (4H, m), 2.45 (6H, s), 2.32 (3H, s), 2.27 (3H, s).
출처 및 근거
- ORD 기록
- ord-5da8fb6e30cc4aae91ad587067d43b6b
- 출처 데이터셋
- uspto-grants-2006_02
- DOI